JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB161312

Recombinant Human SLC7A9 protein (GST tag N-Terminus)

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant Human SLC7A9 protein (GST tag N-Terminus) is a Human Full Length protein, in the 1 to 487 aa range, expressed in Wheat germ, suitable for ELISA, WB.

View Alternative Names

BAT1, SLC7A9, Solute carrier family 7 member 9

1 Images
SDS-PAGE - Recombinant Human SLC7A9 protein (GST tag N-Terminus) (AB161312)
  • SDS-PAGE

Unknown

SDS-PAGE - Recombinant Human SLC7A9 protein (GST tag N-Terminus) (AB161312)

ab161312 on a 12.5% SDS-PAGE stained with Coomassie Blue.

Key facts

Expression system

Wheat germ

Tags

GST tag N-Terminus

Applications

ELISA, WB

applications

Biologically active

No

Accession

P82251

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 8 Constituents: 0.79% Tris HCl, 0.31% Glutathione

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Sequence info

[{"sequence":"MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTEAVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVIKPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNYITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYPASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGIIATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLISVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVVPPEEDPE","proteinLength":"Full Length","predictedMolecularWeight":null,"actualMolecularWeight":null,"aminoAcidEnd":487,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":"Wheat germ","accessionNumber":"P82251","tags":[{"tag":"GST","terminus":"N-Terminus"}]}]

Properties and storage information

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SLC7A9 also known as b(0+)-type amino acid transporter 1 (rBAT) functions as a sodium-independent transporter responsible for the uptake of neutral and basic amino acids. It has a molecular weight of approximately 52 kDa. This transporter is expressed largely in the kidney and small intestine where it plays an important role in amino acid reabsorption. SLC7A9 is part of the solute carrier family 7 which is involved in transporting amino acids across cellular membranes.
Biological function summary

SLC7A9 facilitates the selective transepithelial transport of amino acids through its association with the heavy chain rBAT forming a functional heteromeric complex. This complex ensures effective transport of specific amino acids particularly cystine and dibasic amino acids from the lumen into epithelial cells which is critical for preventing loss of these amino acids in urine. This biological role is integral to maintaining amino acid levels and systemic nitrogen economy highlighting its importance in everyday metabolism.

Pathways

SLC7A9 activity interacts notably within the cystine and arginine metabolism pathways. Here its transporter function complements the action of other solute carriers and enzymes like SLC3A1 its associated partner in the heterodimeric complex to modulate amino acid concentrations within systemic circulation. SLC7A9 also influences the lysine degradation pathway which involves the cellular regulation of lysine levels interplaying with enzymes such as lysine-ketoglutarate reductase to maintain metabolic homeostasis.

SLC7A9 mutations have a significant association with the condition cystinuria a disorder characterized by the excessive excretion of cystine leading to kidney stone formation. Variants of SLC7A9 alter amino acid transport capacity impacting cystine stone formation and accumulation. Similarly disruptions in SLC7A9 function correlate with lysinuric protein intolerance a metabolic disorder linked to impaired lysine metabolism where it shares dysfunction with related protein SLC3A1. Both conditions highlight the importance of SLC7A9 in maintaining amino acid balance and renal health.

Specifications

Form

Liquid

General info

Function

Associates with SLC3A1 to form a functional transporter complex that mediates the electrogenic exchange between cationic amino acids and neutral amino acids, with a stoichiometry of 1 : 1 (PubMed : 16825196, PubMed : 32494597, PubMed : 32817565, PubMed : 8663357). Has system b(0,+)-like activity with high affinity for extracellular cationic amino acids and L-cystine and lower affinity for intracellular neutral amino acids (PubMed : 16825196, PubMed : 32494597, PubMed : 8663357). Substrate exchange is driven by high concentration of intracellular neutral amino acids and the intracellular reduction of L-cystine to L-cysteine (PubMed : 8663357). Required for reabsorption of L-cystine and dibasic amino acids across the brush border membrane in renal proximal tubules.

Sequence similarities

Belongs to the amino acid-polyamine-organocation (APC) superfamily.

Product protocols

Target data

Associates with SLC3A1 to form a functional transporter complex that mediates the electrogenic exchange between cationic amino acids and neutral amino acids, with a stoichiometry of 1 : 1 (PubMed : 16825196, PubMed : 32494597, PubMed : 32817565, PubMed : 8663357). Has system b(0,+)-like activity with high affinity for extracellular cationic amino acids and L-cystine and lower affinity for intracellular neutral amino acids (PubMed : 16825196, PubMed : 32494597, PubMed : 8663357). Substrate exchange is driven by high concentration of intracellular neutral amino acids and the intracellular reduction of L-cystine to L-cysteine (PubMed : 8663357). Required for reabsorption of L-cystine and dibasic amino acids across the brush border membrane in renal proximal tubules.
See full target information SLC7A9

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com